4 participants
Retrospective Study on Caplacizumab-treated Pediatric Patients With Immune-mediated Thrombocytopenic Purpura (iTTP)
- Study Type:
- OBSERVATIONAL
- Last Updated:
- 2022-12-14
- Start Date:
- 2022-06-08
- Completion:
- 2022-10-28
Conditions
- Immune-mediated Thrombocytopenic Purpura
Interventions
- DRUG
No Results Yet